Dr Lalchandani Labs (BOM:541299) FCF Margin % : 0.00% (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dr Lalchandani Labs's Free Cash Flow for the six months ended in Sep. 2023 was ₹0.00 Mil. Dr Lalchandani Labs's Revenue for the six months ended in Sep. 2023 was ₹27.26 Mil. Therefore, Dr Lalchandani Labs's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Dr Lalchandani Labs's current FCF Yield % is -3.20%.

The historical rank and industry rank for Dr Lalchandani Labs's FCF Margin % or its related term are showing as below:

BOM:541299' s FCF Margin % Range Over the Past 10 Years
Min: -38.37 Med: -8.63 Max: 26.87
Current: -5.54

During the past 11 years, the highest FCF Margin % of Dr Lalchandani Labs was 26.87%. The lowest was -38.37%. And the median was -8.63%.

BOM:541299's FCF Margin % is ranked better than
57.21% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs BOM:541299: -5.54

Dr Lalchandani Labs FCF Margin % Historical Data

The historical data trend for Dr Lalchandani Labs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs FCF Margin % Chart

Dr Lalchandani Labs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

-38.37

-11.65

-11.24

8.07

-6.02

Dr Lalchandani Labs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
FCF Margin %	Get a 7-Day Free Trial													16.28	-12.14	-130.00	96.71	-

Competitive Comparison of Dr Lalchandani Labs's FCF Margin %

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Lalchandani Labs's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's FCF Margin % falls into.

Dr Lalchandani Labs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dr Lalchandani Labs's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-3.035	/	50.402
	=	-6.02 %

Dr Lalchandani Labs's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0	/	27.261
	=	0.00 %

Dr Lalchandani Labs FCF Margin % Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Lalchandani Labs (BOM:541299) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048

Website

https://www.lalchandanipathlab.com

Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines